Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies
出版年份 2022 全文链接
标题
Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies
作者
关键词
-
出版物
PHARMACOLOGICAL RESEARCH
Volume 184, Issue -, Pages 106456
出版商
Elsevier BV
发表日期
2022-09-16
DOI
10.1016/j.phrs.2022.106456
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
- (2022) Felipe Batalini et al. CLINICAL CANCER RESEARCH
- Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties
- (2022) Rocío Jiménez-Guerrero et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
- (2022) Shuohui Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1)
- (2022) Liping Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals
- (2022) Yinci Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
- (2022) Wenjing Wang et al. Molecular Cancer
- Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44+CD133+ Tumor-Initiating Caco-2 Cells In Vitro and In Vivo
- (2022) Junghoon Kim et al. Frontiers in Cell and Developmental Biology
- Pancreatic tumor eradication via selective Pin1 inhibition in cancer-associated fibroblasts and T lymphocytes engagement
- (2022) Jiaye Liu et al. Nature Communications
- Drug resistance and Cancer stem cells
- (2021) Yuan Li et al. Cell Communication and Signaling
- Pin1 Promotes NLRP3 Inflammasome Activation by Phosphorylation of p38 MAPK Pathway in Septic Shock
- (2021) Ruijie Dong et al. Frontiers in Immunology
- Cancer drug resistance induced by EMT: novel therapeutic strategies
- (2021) Javier De Las Rivas et al. ARCHIVES OF TOXICOLOGY
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
- (2021) Christian Dubiella et al. Nature Chemical Biology
- RAF-MEK-ERK pathway in cancer evolution and treatment
- (2021) Rahim Ullah et al. SEMINARS IN CANCER BIOLOGY
- Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
- (2021) Lauren MacDonagh et al. Translational Oncology
- (–)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1
- (2021) Fernanda Isabel Della Via et al. Scientific Reports
- Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor
- (2021) Jacky K. Leung et al. Communications Biology
- Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
- (2021) Kazuhiro Koikawa et al. CELL
- Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair
- (2021) Shenghui Qin et al. FREE RADICAL BIOLOGY AND MEDICINE
- EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells
- (2021) Wenbing Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer
- (2021) Jing-Qiang Huang et al. Journal of Translational Medicine
- The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma
- (2021) Yuting Wang et al. CELLULAR ONCOLOGY
- Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway
- (2021) Xiaoxia Yang et al. Acta Pharmaceutica Sinica B
- MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway
- (2021) Ghmkin Hassan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression
- (2021) Yuhong Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Peptidyl‐prolyl cis‐trans isomerase NIMA‐interacting 1 directly binds and stabilizes Nrf2 in breast cancer
- (2021) Soma Saeidi et al. FASEB JOURNAL
- Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
- (2021) Ruo Yu Meng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis
- (2021) Yupeng Liu et al. MOLECULAR PHARMACEUTICS
- STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma
- (2021) Ana Paula Morelli et al. NEOPLASIA
- Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells
- (2020) Alagesan Seetha et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
- (2020) Wenxiu Yao et al. BMC CANCER
- Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition
- (2020) Man-Li Luo et al. CANCER RESEARCH
- The NFκB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
- (2020) Irida Kastrati et al. MOLECULAR CANCER RESEARCH
- Juglone potentiates BRAF inhibitor‑induced apoptosis in melanoma through reactive oxygen species and the p38‑p53 pathway
- (2020) Zheng Li et al. Molecular Medicine Reports
- Identification of a potent and selective covalent Pin1 inhibitor
- (2020) Benika J. Pinch et al. Nature Chemical Biology
- Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells
- (2020) Wei-Chun Hu et al. Frontiers in Oncology
- Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance
- (2020) Wenchen Pu et al. Frontiers in Cell and Developmental Biology
- Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics
- (2020) Ji Hoon Yu et al. Frontiers in Cell and Developmental Biology
- TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance
- (2020) Xiao-ming Jiang et al. ACTA PHARMACOLOGICA SINICA
- Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells
- (2020) Liyun Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
- (2020) Qiao Zheng et al. BIOSCIENCE REPORTS
- Protein sumoylation with SUMO1 promoted by Pin1 in glioma stem cells augments glioblastoma malignancy
- (2020) Aili Zhang et al. NEURO-ONCOLOGY
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib
- (2020) Jia Xiong Ming et al. JOURNAL OF ETHNOPHARMACOLOGY
- Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer
- (2019) Shinichiro Nakada et al. ANNALS OF SURGICAL ONCOLOGY
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- An IRAK1–PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy
- (2019) Peter H. Liu et al. NATURE CELL BIOLOGY
- (−)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway
- (2019) Xiaoqin La et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
- (2019) Fang Wei et al. CANCER LETTERS
- Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β‐catenin oncogenic pathways
- (2019) Zhenzhen Zhang et al. MOLECULAR CARCINOGENESIS
- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance
- (2019) Matthew J. Sale et al. Nature Communications
- Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells
- (2019) Prem Khanal et al. Scientific Reports
- Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells
- (2019) Jung Mi Byun et al. ACTA ONCOLOGICA
- Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
- (2019) Junli Deng et al. BMC CANCER
- Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
- (2019) Walhan Alshaer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC
- (2019) Jiao Meng et al. OncoTargets and Therapy
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4
- (2019) Negar Sheikh‐Zeineddini et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
- (2019) Fan Liang et al. Oncogenesis
- All-trans Retinoic Acid Overcomes Acquired Resistance to PLX4032 via Inhibition of PIN1 in Melanoma Cells
- (2019) GARAM KIM et al. ANTICANCER RESEARCH
- Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
- (2019) Yusuke Nakatsu et al. CANCER LETTERS
- De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties
- (2019) Yuting Wang et al. EXPERIMENTAL CELL RESEARCH
- Pin1 inhibition sensitizes chemotherapy in gastric cancer cells by targeting stem-cell like traits and multiple biomarkers
- (2019) Zhen-Zhen Zhang et al. MOLECULAR CANCER THERAPEUTICS
- miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
- (2019) Yu Gao et al. Scientific Reports
- Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms
- (2019) Songyin Huang et al. Frontiers in Cell and Developmental Biology
- MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
- (2018) Lingtao Jin et al. CANCER CELL
- Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
- (2018) Luke Piggott et al. CLINICAL CANCER RESEARCH
- SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development
- (2018) Garam Kim et al. FASEB JOURNAL
- 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling
- (2018) Jing Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of Cdk1–LATS–Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells
- (2018) Benjamin Yeung et al. MOLECULAR CANCER RESEARCH
- Molecular mechanism and cytotoxicity of allicin and all-trans retinoic acid against CD44 + versus CD117 + melanoma cells
- (2018) Bahareh Mohammadi Jobani et al. PHYTOMEDICINE
- Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
- (2018) Chao Yu et al. Theranostics
- Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
- (2018) Norashikin Zakaria et al. Frontiers in Oncology
- EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells
- (2018) Pan Jiang et al. MOLECULAR CARCINOGENESIS
- Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation
- (2018) Zixing Liu et al. ONCOGENE
- Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin
- (2018) Hanmei Li et al. PHYTOMEDICINE
- Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer
- (2018) Jianhua Mao et al. Cell Death & Disease
- Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
- (2018) Yang Chen et al. Cell Death & Disease
- Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
- (2018) Shingo Kozono et al. Nature Communications
- All-trans retinoic acid reverses epithelial-mesenchymal transition in paclitaxel-resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions
- (2018) Guiling Shi et al. CANCER SCIENCE
- Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
- (2018) Maria Elena Pisanu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop
- (2018) Yongxin Qiu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells
- (2018) Joshua Heyza et al. Nutrients
- PIN1 in Cell Cycle Control and Cancer
- (2018) Chi-Wai Cheng et al. Frontiers in Pharmacology
- Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway
- (2018) Jichuang Wang et al. CANCER LETTERS
- SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway
- (2017) S.-L. Xie et al. INTERNATIONAL JOURNAL OF CANCER
- Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop
- (2017) Bhushan Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding
- (2017) Peng Liao et al. MOLECULAR CELL
- Juglone potentiates TRAIL-induced apoptosis in human melanoma cells via activating the ROS-p38-p53 pathway
- (2017) Xiao Liu et al. Molecular Medicine Reports
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
- (2017) Liang Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer
- (2017) Hongsheng Tang et al. Oncotarget
- Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma
- (2017) Min Zheng et al. Oncotarget
- Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer
- (2017) Nguyen Thi Thuy Phuong et al. Oncotarget
- Sensitizing effect of juglone is mediated by down regulation of Notch1 signaling pathway in trastuzumab-resistant SKBR3 cells
- (2016) Soraya Sajadimajd et al. APOPTOSIS
- ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5
- (2016) Hui-Lung Sun et al. CANCER CELL
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
- (2016) Chien-Han Yuan et al. ENVIRONMENTAL TOXICOLOGY
- Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation
- (2016) RYOTA KURIMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas
- (2016) Karen A. Boehme et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line
- (2016) Guo-zhong Yi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype
- (2016) Yuji Sakuma et al. LABORATORY INVESTIGATION
- Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer
- (2016) Tao Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- NF-κB in cancer therapy
- (2015) Feng Li et al. ARCHIVES OF TOXICOLOGY
- Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
- (2015) Rong Sun et al. BIOMATERIALS
- Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
- (2015) Jessica Lo et al. HEPATOLOGY
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
- (2015) Shuo Wei et al. NATURE MEDICINE
- Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling
- (2015) F Kruiswijk et al. ONCOGENE
- Epigallocatechin-3-Gallate Potentiates the Effect of Curcumin in Inducing Growth Inhibition and Apoptosis of Resistant Breast Cancer Cells
- (2014) Shengpeng Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
- (2014) M. Tanioka et al. BREAST CANCER RESEARCH AND TREATMENT
- Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem-like Cell Traits in Breast Cancer
- (2014) M.-L. Luo et al. CANCER RESEARCH
- Prolyl isomerase Pin1 in cancer
- (2014) Zhimin Lu et al. CELL RESEARCH
- ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
- (2014) Hao Deng et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
- (2014) H. Clevers et al. SCIENCE
- Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation
- (2014) Bo Zhai et al. TUMOR BIOLOGY
- Arsenic reverses glioblastoma resistance to mTOR-targeted therapies
- (2013) Akio Iwanami et al. CELL CYCLE
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
- (2013) Srikala S. Sridhar et al. EUROPEAN UROLOGY
- All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer
- (2013) Yang Zhang et al. JOURNAL OF HEPATOLOGY
- Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor
- (2013) T M Becker et al. ONCOGENE
- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors
- (2013) M Nishi et al. ONCOGENE
- The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer
- (2013) Chiara Lucchetti et al. PLoS One
- Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell
- (2012) Ning Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Arsenic compounds: revived ancient remedies in the fight against human malignancies
- (2012) Jian-Xiang Liu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition
- (2012) Jung-Ae Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
- (2012) Y. Wu et al. MOLECULAR CANCER RESEARCH
- Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells
- (2012) LU ZHOU et al. ONCOLOGY REPORTS
- Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
- (2011) D. V. Urusova et al. Cancer Prevention Research
- Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 Expression
- (2011) L. Dhandapani et al. CANCER RESEARCH
- A critical step for JNK activation: isomerization by the prolyl isomerase Pin1
- (2011) J E Park et al. CELL DEATH AND DIFFERENTIATION
- Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
- (2011) Tae Ho Lee et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Regulation of Estrogen Receptor N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1
- (2011) P. Rajbhandari et al. MOLECULAR AND CELLULAR BIOLOGY
- PI3-Kinase/p38 kinase-dependent E2F1 activation is critical for pin1 induction in tamoxifen-resistant breast cancer cells
- (2011) Kwang Youl Lee et al. MOLECULES AND CELLS
- Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells
- (2011) P Khanal et al. ONCOGENE
- Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins
- (2011) Yih-Cherng Liou et al. TRENDS IN BIOCHEMICAL SCIENCES
- Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells
- (2010) Soo Jin Oh et al. FOOD AND CHEMICAL TOXICOLOGY
- The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer
- (2010) Gwang Mo Namgoong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells
- (2010) Makoto Saegusa et al. JOURNAL OF PATHOLOGY
- (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line
- (2010) F. Farabegoli et al. PHYTOMEDICINE
- Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
- (2009) T Noda et al. BRITISH JOURNAL OF CANCER
- Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells
- (2009) Mi Ra Kim et al. CANCER SCIENCE
- Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression
- (2009) M. R. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Pinning down HER2–ER crosstalk in SMRT regulation
- (2009) Akihide Ryo et al. TRENDS IN BIOCHEMICAL SCIENCES
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer
- (2008) Q. Ding et al. CANCER RESEARCH
- Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
- (2008) Kristopher J. Stanya et al. JOURNAL OF CELL BIOLOGY
- Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability
- (2008) Prudence B Lam et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now